// App-Quantinova.ai

S1058 2016 AHA : Proprotein Convertase Subtilisin/Kexin Type 9 May Associate With Lipoproteins Through Lipid Interactions

Researchers

Presenter

  • Natalie Goto

Principal Investigators

  • Thomas A Lagace

Medical Centers

  • University of Ottawa Heart Institute, Ottawa, ON, Canada

  • Univ of Ottawa, Ottawa, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Hypercholesterolemia, Familial, 1

Biomarkers

  • Proprotein convertase subtilisin/kexin type 9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved